Dr. Adam M. Katz, MD

Dr. Katz practices at Advanced Eye Surgery Center - Vero Beach in Vero Beach, Florida.

Dr. Katz's NPI, 1790772101, was assigned on September 30, 2005. Dr. Katz graduated from Albany Medical College in 1992. Dr. Katz holds Florida license 105598.

Dr. Katz's primary practice is Advanced Eye Surgery Center - Vero Beach, at 3500 Us Highway 1, Vero Beach, FL 32960. The practice phone is (772) 229-1404.

Dr. Katz's primary practice is Advanced Eye Surgery Center - Vero Beach in Vero Beach, Florida. Dmand AI also links Dr. Katz to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Katz practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Katz's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Katz is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Katz's licenses on file in 6 states: Florida, Georgia, New York, Arkansas, Tennessee and Alabama.

Dmand AI lists age-related macular degeneration, cataract, conjunctivitis, dry eye, eyelid inflammation, glaucoma, hypertensive retinopathy and inflammation of iris among the conditions Dr. Katz treats.

CMS data shows 8,807 Medicare services from Dr. Katz across 15 procedure codes in 2024, for 2,315 Medicare patients. Medicare paid $653,084 for them.

CMS counts 2,315 Medicare patients who saw Dr. Katz in 2024. The largest group is 75 to 84, with 1,018 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 2% are also on Medicaid. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Katz's median patient age at 77, with 57% women.

In 2024, Dr. Katz wrote 281 Medicare Part D claims for 108 patients. 44% of them were for generic drugs. CMS names the drug for 215 of them, across 8 drugs with 11 or more claims each, at $46,471 in total drug cost. In 2023, CMS named 315 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Katz for performance year 2024, reported as part of a group. Dr. Katz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 45 procedures of cataract surgery by Dr. Katz, more than 61% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Katz. Dr. Katz's most frequent co-authors are Lama Al-Aswad, MD, Emery Cason Jamerson and William J. Mallon, MD.

CMS Open Payments shows 176 general payments to Dr. Katz from 44 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 65% of the total. Allergan Inc. paid the most, $12,466.

Dmand AI lists 4 awards for Dr. Katz, most recently John R. Brayton, Jr., MD, Leadership Award in 2019.

Dr. Katz graduated from Albany Medical College in 1992. Dr. Katz is a member of ASRS and Florida Society of Ophthalmology.

Dr. Katz is in network with 12 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.